coumarin has been researched along with aspirin in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (35.14) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 4 (10.81) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, K; Kansy, M; Senner, F | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Balliano, TL; Barbosa, G; Carvalho, VF; da Silva, BA; de Souza, ET; Lima, LM; Martins, IRR; Martins, MA; Medeiros, MM; Moraes Junior, MO; Nunes, IKDC; Silva, PMR; Silva, SWD | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bär, FW; de Swart, JB; van der Veen, FH; van Ommen, V; van Oppen, J; Wellens, HJ | 1 |
| Kessler, CM | 1 |
| Beer, JH; Rihs, F; Sturzenegger, M | 1 |
| Debruyne, FM; Doesburg, W; vd Meijden, AP; Witjes, JA | 1 |
| Dick, B; Jacobi, FK | 1 |
| Fondevila, CG; Frontroth, J; Lazzari, MA; Meschengieser, SS; Santarelli, MT | 1 |
| Boda, Z; Bódi, A; Csapó, K; Hegedús, I; Medgyesi, F; Pfliegler, G; Voith, L | 1 |
| Anderson, LM; Jones, AB; Liao, AM; Liu, Y; Smith, TJ; Yang, CS | 1 |
| Schipper, JP | 1 |
| Ghali, JK | 1 |
| Grobbee, DE; Kardinaal, AF; Kruijssen, DA; Princen, HM; van de Vijver, LP; van Duyvenvoorde, W; van Poppel, G | 1 |
| Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F | 1 |
| Franke, A | 1 |
| Bailey, SR; Baim, DS; Cleman, MW; Deutsch, E; Diver, DJ; Fitzgerald, PJ; Hayase, M; Kuntz, RE; Leon, MB; Metz, JA; Moses, JW; Oesterle, SN; Oshima, A; Overlie, PA; Pepine, CJ; Safian, RD; Shani, J; Simonton, CA; Smalling, RW; Teirstein, PS; Yeung, AC; Yock, PG; Zidar, JP | 1 |
| Buurma, H; Egberts, AC; Leufkens, HG; Rahimtoola, H; Tijssen, CC | 1 |
| Graatsma, HH; Stricker, BH; Visser, LE | 1 |
| Altorjay, I; Palatka, K; Tornai, I; Udvardy, M | 1 |
| Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP | 1 |
| Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ | 1 |
| Baumgartner, RW; Gandjour, J; Georgiadis, D; Zeindler, J | 1 |
| Cieślik, T; Cieślik-Bielewska, A; Pelc, R | 1 |
| Lengyel, M | 1 |
| Belvís, R; Bravo, Y; Castellanos, M; Cocho, D; Egido, J; Geffner, D; Gich, I; Gil-Núñez, A; Marta, J; Martí-Fàbregas, J; Martí-Vilalta, JL; Millán, M; Navarro, R; Obach, V; Palomeras, E; Rodríguez-Campello, A | 1 |
| Rath, W; Richter, ON | 1 |
| Aengevaeren, WR; Brouwer, MA; Kievit, PC; van den Bergh, PJ; Veen, G; Verheugt, FW | 1 |
| Grzywna, E; Krupa, M; Moskała, M; Składzień, T | 1 |
| Erastov, AA; Kostanyan, AE; Shishilov, ON | 1 |
| Erastov, AA; Kostanyan, AE | 1 |
6 review(s) available for coumarin and aspirin
| Article | Year |
|---|---|
The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.
Topics: Aspirin; Coumarins; Fibrinolytic Agents; Heparin; Humans; Thromboembolism; Thrombolytic Therapy; Thrombosis | 1991 |
Contemporary issues in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Anticoagulants; Aspirin; Community Health Services; Coumarins; Heart Failure; Humans; Hypertension; Myocardial Ischemia; Stroke Volume; United States; Ventricular Dysfunction, Left | 1999 |
[Acute gastrointestinal bleeding in patients with antithrombotic therapy].
Topics: Acute Disease; Anticoagulants; Aspirin; Coumarins; Deamino Arginine Vasopressin; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Hemostatics; Heparin; Humans; Thrombolytic Therapy; Ticlopidine | 2002 |
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke | 2005 |
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stents; Ticlopidine | 2005 |
[Thromboembolic diseases in pregnancy].
Topics: Algorithms; Anticoagulants; Aspirin; Contraindications; Coumarins; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2007 |
7 trial(s) available for coumarin and aspirin
| Article | Year |
|---|---|
Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Coumarins; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Time Factors | 1997 |
[Coumarin combined with low-dose acetylsalicylic acid in the prevention of thromboembolic complications in patients with mitral and aortic valve prostheses].
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Coumarins; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Thromboembolism | 1997 |
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Survival Analysis; Thromboembolism; Treatment Outcome | 1999 |
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Stents; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2000 |
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Disease-Free Survival; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Treatment Outcome | 2002 |
Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Arterial Diseases; Cerebrovascular Disorders; Constriction, Pathologic; Coumarins; Female; Humans; Male; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Treatment Outcome | 2006 |
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
Topics: Aged; Anticoagulants; Aspirin; Coronary Occlusion; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Treatment Outcome | 2009 |
24 other study(ies) available for coumarin and aspirin
| Article | Year |
|---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid | 2002 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; Humans; Hydrazones; Hypersensitivity; Lung; Male; Mice | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Dipyridamole; Drug Administration Schedule; Electrocardiography; Exercise Test; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Premedication; Recurrence; Stents | 1992 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fibrinopeptide A; Heart Valve Prosthesis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Ultrasonography, Doppler, Transcranial | 1995 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Coumarins; Dipyridamole; Fibrin; Humans; Male; Random Allocation; Urinary Bladder Neoplasms; Warfarin | 1993 |
[Cataract surgery and anticoagulation--current status].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Coumarins; Heparin; Humans; Patient Care Team; Prothrombin Time; Risk Factors; Thromboembolism | 1996 |
Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
Topics: Animals; Aspirin; Biotransformation; Carbon Monoxide; Coumarins; Cytochrome P-450 Enzyme System; Erythrocebus patas; Female; Isothiocyanates; Lipoxygenase; Lung; Masoprocol; Microsomes; Microsomes, Liver; Nitrosamines; Oxygenases; Prostaglandin-Endoperoxide Synthases | 1997 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Humans; Ischemic Attack, Transient | 1998 |
Oxidation of LDL and extent of peripheral atherosclerosis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cholesterol, Dietary; Coumarins; Diet, Fat-Restricted; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Odds Ratio; Risk Factors | 1999 |
[Prevention of embolism in atrial septal defects?].
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Coumarins; Embolism; Female; Fibrinolytic Agents; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Time Factors; Venous Thrombosis | 2000 |
Reduction in the intensity of abortive migraine drug use during coumarin therapy.
Topics: Anticoagulants; Aspirin; Coumarins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergotamine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Severity of Illness Index; Sumatriptan; Vasoconstrictor Agents | 2001 |
Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Cohort Studies; Contraindications; Coumarins; Drug Interactions; Drug Prescriptions; Female; Glucocorticoids; Humans; Male; Osteoarthritis; Peptic Ulcer Hemorrhage; Retrospective Studies | 2002 |
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Based Medicine; Female; Humans; Logistic Models; Male; Middle Aged; Practice Patterns, Physicians'; Primary Health Care; Risk Assessment; Thromboembolism | 2003 |
Oral surgery procedures in patients on anticoagulants. Preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Coumarins; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oral Surgical Procedures; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Treatment Outcome | 2005 |
[Influence of anticoagulants on the appearance of chronic subdural hematoma].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Chronic Disease; Coumarins; Female; Hematoma, Subdural; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Poland; Surveys and Questionnaires | 2009 |
Multiple dual mode counter-current chromatography with variable duration of alternating phase elution steps.
Topics: Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Models, Theoretical; Salicylic Acid | 2014 |
Theoretical study of closed-loop recycling liquid-liquid chromatography and experimental verification of the theory.
Topics: Acetates; Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Ethanol; Hexanes; Models, Theoretical; Recycling; Reproducibility of Results; Solutions; Solvents; Water | 2016 |